Disappearance of Racial Disparities in Gastrointestinal Stromal Tumor Outcomes

Journal of the American College of Surgeons

Volumn 209, Issue 1, 2009, Pages 7-16

  Cheung, Michael C ^a   Zhuge, Ying ^a   Yang, Relin ^a   Koniaris, Leonidas G ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUCASIAN; DEMOGRAPHY; FEMALE; GASTROINTESTINAL STROMAL TUMOR; HISPANIC; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RACE DIFFERENCE; SOCIOECONOMICS; SURGICAL MORTALITY;

ADULT; AFRICAN AMERICANS; AGED; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; SEER PROGRAM; SOCIOECONOMIC FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 67349264058     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2009.03.018     Document Type: Article

References (31)

1. Gutierrez J.C., De Oliveira L.O., Perez E.A., et al. Optimizing diagnosis, staging, and management of gastrointestinal stromal tumors. J Am Coll Surg 205 (2007) 479-491 (Quiz 524)
2. Perez E.A., Livingstone A.S., Franceschi D., et al. Current incidence and outcomes of gastrointestinal mesenchymal tumors including gastrointestinal stromal tumors. J Am Coll Surg 202 (2006) 623-629
3. Miettinen M., Sobin L.H., and Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol 29 (2005) 52-68
4. Khanna A., Walker G.R., Livingstone A.S., et al. Is adjuvant 5-FU-based chemoradiotherapy for resectable pancreatic adenocarcinoma beneficial?. A meta-analysis of an unanswered question. J Gastrointest Surg 10 (2006) 689-697
5. Plaat B.E., Hollema H., Molenaar W.M., et al. Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins. J Clin Oncol 18 (2000) 3211-3220
6. DeMatteo R.P., Lewis J.J., Leung D., et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 231 (2000) 51-58
7. Buchdunger E., Cioffi C.L., Law N., et al. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J Pharmacol Exp Ther 295 (2000) 139-145
8. Buchdunger E., Zimmermann J., Mett H., et al. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Cancer Res 56 (1996) 100-104
9. Druker B.J., Tamura S., Buchdunger E., et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 2 (1996) 561-566
10. Tran T., Davila J.A., and El-Serag H.B. The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol 100 (2005) 162-168
11. Gutierrez J.C., Perez E.A., Franceschi D., et al. Outcomes for soft-tissue sarcoma in 8249 cases from a large state cancer registry. J Surg Res 141 (2007) 105-114
12. Perez E.A., Gutierrez J.C., Jin X., et al. Surgical outcomes of gastrointestinal sarcoma including gastrointestinal stromal tumors: a population-based examination. J Gastrointest Surg 11 (2007) 114-125
13. Kindblom L.G., Remotti H.E., Aldenborg F., and Meis-Kindblom J.M. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 152 (1998) 1259-1269
14. Hirota S., Isozaki K., Moriyama Y., et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279 (1998) 577-580
15. Corless C.L., Schroeder A., Griffith D., et al. PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib. J Clin Oncol 23 (2005) 5357-5364
16. Fletcher J.A., Fletcher C.D., Rubin B.P., et al. KIT gene mutations in gastrointestinal stromal tumors: more complex than previously recognized?. Am J Pathol 161 (2002) 737-738 author reply 738-739
17. Zhuge Y., Cheung M.C., Yang R., and Koniaris L.G. Diagnosing gastrointestinal stromal tumors before the year 2000. Cancer Epidemiol Biomarkers Prev 18 (2009) 1013-1014
18. Clary B.M., DeMatteo R.P., Lewis J.J., et al. Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and retroperitoneum: a clinical comparison. Ann Surg Oncol 8 (2001) 290-299
19. Nikfarjam M., Kimchi E., Shereef S., et al. Surgical outcomes of patients with gastrointestinal stromal tumors in the era of targeted drug therapy. J Gastrointest Surg 12 (2008) 2023-2031
20. Artinyan A., Kim J., Soriano P., et al. Metastatic gastrointestinal stromal tumors in the era of imatinib: improved survival and elimination of socioeconomic survival disparities. Cancer Epidemiol Biomarkers Prev 17 (2008) 2194-2201
21. Freeman H.P. Poverty, culture, and social injustice: determinants of cancer disparities. CA Cancer J Clin 54 (2004) 72-77
22. Goodwin W.J., Thomas G.R., Parker D.F., et al. Unequal burden of head and neck cancer in the United States. Head Neck 30 (2008) 358-371
23. Kogevinas M., and Porta M. Socioeconomic differences in cancer survival: a review of the evidence. IARC Sci Publ 138 (1997) 177-206
24. Sudano J.J., and Baker D.W. Explaining US racial/ethnic disparities in health declines and mortality in late middle age: the roles of socioeconomic status, health behaviors, and health insurance. Soc Sci Med 62 (2006) 909-922
25. Ward E., Jemal A., Cokkinides V., et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 54 (2004) 78-93
26. Molina M.A., Cheung M.C., Perez E.A., et al. African American and poor patients have a dramatically worse prognosis for head and neck cancer: an examination of 20,915 patients. Cancer 113 (2008) 2797-2806
27. Henschke U.K., Leffall Jr. L.D., Mason C.H., et al. Alarming increase of the cancer mortality in the U.S. black population (1950-1967). Cancer 31 (1973) 763-768
28. Byers T., Mouchawar J., Marks J., et al. The American Cancer Society challenge goals. How far can cancer rates decline in the US by the year 2015?. Cancer 86 (1999) 715-727
29. Gutierrez J.C., Perez E.A., Moffat F.L., et al. Should soft tissue sarcomas be treated at high-volume centers?. An analysis of 4205 patients. Ann Surg 245 (2007) 952-958
30. Perez E.A., Gutierrez J.C., Moffat Jr. F.L., et al. Retroperitoneal and truncal sarcomas: prognosis depends upon type not location. Ann Surg Oncol 14 (2007) 1114-1122
31. Blay J.Y., and Le Cesne A. Gastrointestinal stromal tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 18 (2007) 27-29